A renaissance of positive inotropic interventions to treat heart failure?
D000493:Allopurinol / Q000627:therapeutic use; D000818:Animals; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005609:Free Radicals / Q000378:metabolism; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D023421:Models, Animal; D009206:Myocardium / Q000378:metabolism; D010100:Oxygen / Q000378:metabolism; D010117:Oxypurinol / Q000627:therapeutic use*; D051381:Rats; D014969:Xanthine Oxidase / Q000037:antagonists & inhibitors*
D004791:Enzyme Inhibitors; D005609:Free Radicals; D000493:Allopurinol; D014969:Xanthine Oxidase; D010117:Oxypurinol; D010100:Oxygen